Proxima Bio, Inc.
through Jun 10, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Jan 21, 2026 · D | Jun 10, 2026 · D/A | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $88,500,025 | $91,454,999 | $2,954,974 |
| Reported amount sold | $86,264,999 | $91,454,999 | $5,190,000 |
| Reported investor count | — | 11 | — |
| Reported minimum investment | $1 | $1 | $0 |
Earlier SEC source: 0002104665-26-000001 · Later SEC source: 0002104665-26-000003
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $91,454,999
- Reported amount sold
- $91,454,999
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Contact info
Log in to look up an email or website for this issuer.
Form D filings (2)
-
0002104665-26-000003D/A · Jun 10, 2026 · Other Health CareOffering: $91,454,999Sold: $91,454,999
-
0002104665-26-000001D · Jan 21, 2026 · Other Health CareOffering: $88,500,025Sold: $86,264,999